Interim data released from INSPIRE study on interleukin-7.
D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D004305:Dose-Response Relationship, Drug; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006801:Humans; D015851:Interleukin-7 / Q000008:administration & dosage* / Q000235:genetics / Q000627:therapeutic use; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000008:administration & dosage* / Q000235:genetics / Q000627:therapeutic use; D016896:Treatment Outcome
D015851:Interleukin-7; D011994:Recombinant Proteins